| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.049 | 0.3 |